Ascenta Therapeutics
ClosedPhiladelphia, United States · Founded 2003
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2003
- Business Model
- B2B
About
Ascenta Therapeutics is a privately-held, clinical-stage biopharmaceutical company located in the Greater Philadelphia area dedicated to efficient oncology drug development. Its portfolio consists of apoptosis-triggering small molecules that target protein-protein interactions, including two clinical-stage compounds, AT-101 and AT-406. In June 2010, Ascenta announced a $398 million global collaboration and licensing agreement with sanofi-aventis for a third program targeting the p53-HDM2 protein-protein interaction.
Summary
Ascenta Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2003.
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ascenta-therapeutics"><img src="https://indexed.vc/api/badge/company/ascenta-therapeutics" alt="Ascenta Therapeutics on Indexed.vc" width="260" height="76" /></a>